| [1] |
Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke 2022; 17 (1):18-29.
|
| [2] |
Duncan PW, Bushnell C, Sissine M, Coleman S, Lutz BJ, Johnson AM, et al. Comprehensive stroke care and outcomes: time for a paradigm shift. Stroke 2021; 52(1):385-93.
|
| [3] |
Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a metaanalysis of individual patient data from five randomised trials. Lancet 2016; 387(10029):1723-31.
|
| [4] |
Huo X, Ma G, Tong X, Zhang X, Pan Y, Nguyen TN, et al. Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med 2023; 388 (14):1272-83.
|
| [5] |
Tiedt S, Buchan AM, Dichgans M, Lizasoain I, Moro MA, Lo EH. The neurovascular unit and systemic biology in stroke—implications for translation and treatment. Nat Rev Neurol 2022; 18(10):597-612.
|
| [6] |
Gao HM, Chen H, Cui GY, Hu JX. Damage mechanism and therapy progress of the blood-brain barrier after ischemic stroke. Cell Biosci 2023; 13(1):196.
|
| [7] |
Bieri G, Schroer AB, Villeda SA. Blood-to-brain communication in aging and rejuvenation. Nat Neurosci 2023; 26:379-93.
|
| [8] |
The National Institute of Neurological Disorders, Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333(24):1581-8.
|
| [9] |
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;
359(13):1317-29.
|
| [10] |
Karamchandani RR, Rhoten JB, Strong D, Chang B, Asimos AW. Mortality after large artery occlusion acute ischemic stroke. Sci Rep 2021; 11(1):10033.
|
| [11] |
Berkhemer OA, Fransen PSS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372(1):11-20.
|
| [12] |
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378(8):708-18.
|
| [13] |
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378(1):11-21.
|
| [14] |
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;
50(12):e344-418.
|
| [15] |
Jovin TG, Li C, Wu L, Wu C, Chen J, Jiang C, et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med 2022;
387 (15):1373-84.
|
| [16] |
Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, et al. Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med 2022; 387 (15):1361-72.
|
| [17] |
Nam HS, Kim YD, Heo J, Lee H, Jung JW, Choi JK, et al. Intensive vs conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke: the OPTIMAL-BP randomized clinical trial. JAMA 2023; 330(9):832-42.
|
| [18] |
Yoshimura S, Sakai N, Yamagami H, Uchida K, Beppu M, Toyoda K, et al. Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med 2022; 386(14):1303-13.
|
| [19] |
Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019; 18(4):394-405.
|
| [20] |
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi- Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52(7):e364-467.
|
| [21] |
Zhang Y, Jiang M, Gao Y, Zhao W, Wu C, Li C, et al. ‘‘No-reflow” phenomenon in acute ischemic stroke. J Cereb Blood Flow Metab 2024; 44(1):19-37.
|
| [22] |
Wu D, Li M, Fisher M, Ji X. Brain cytoprotection of ischemic stroke in the era of effective reperfusion. Sci Bull 2022; 67(23):2372-5.
|
| [23] |
Lapchak PA. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin Pharmacother 2010; 11(10):1753-63.
|
| [24] |
He W, Zhang Z, Sha X. Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke. Biomaterials 2021; 277:121111.
|
| [25] |
Gong Z, Guo J, Liu B, Guo Y, Cheng C, Jiang Y, et al. Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds. Front Immunol 2023; 14:1287857.
|
| [26] |
El Hadri K, Smith R, Duplus E, El Amri C. Inflammation, oxidative stress, senescence in atherosclerosis: thioredoxine-1 as an emerging therapeutic target. Int J Mol Sci 2021; 23(1):77.
|
| [27] |
Ishikawa H, Tajiri N, Shinozuka K, Vasconcellos J, Kaneko Y, Lee HJ, et al. Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation. Stroke 2013; 44(12):3473-81.
|
| [28] |
Tuazon JP, Castelli V, Borlongan CV. Drug-like delivery methods of stem cells as biologics for stroke. Expert Opin Drug Deliv 2019; 16(8):823-33.
|
| [29] |
Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 2005; 103(1):38-45.
|
| [30] |
Eren F, Yilmaz SE. Neuroprotective approach in acute ischemic stroke: a systematic review of clinical and experimental studies. Brain Circ 2022; 8 (4):172-9.
|
| [31] |
Li F, Gao J, Kohls W, Geng X, Ding Y. Perspectives on benefit of early and prereperfusion hypothermia by pharmacological approach in stroke. Brain Circ 2022; 8(2):69-75.
|
| [32] |
Huang L, Chen Y, Liu R, Li B, Fei X, Li X, et al. P-glycoprotein aggravates blood brain barrier dysfunction in experimental ischemic stroke by inhibiting endothelial autophagy. Aging Dis 2022; 13(5):1546-61.
|
| [33] |
Qi L, Wang F, Sun X, Li H, Zhang K, Li J. Recent advances in tissue repair of the blood-brain barrier after stroke. J Tissue Eng 2024; 15:20417314241226551.
|
| [34] |
Xiong Y, Wakhloo AK, Fisher M. Advances in acute ischemic stroke therapy. Circ Res 2022; 130(8):1230-51.
|
| [35] |
Sato Y, Falcone-Juengert J, Tominaga T, Su H, Liu J. Remodeling of the neurovascular unit following cerebral ischemia and hemorrhage. Cells 2022; 11(18):2823.
|
| [36] |
Mo Y, Xu W, Fu K, Chen H, Wen J, Huang Q, et al. The dual function of microglial polarization and its treatment targets in ischemic stroke. Front Neurol 2022; 13:921705.
|
| [37] |
Liu B, Gu Y, Pei S, Peng Y, Chen J, Pham LV, et al. Interleukin-1 receptor associated kinase (IRAK)-M-mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE). J Autoimmun 2019; 102:77-88.
|
| [38] |
Kamal FZ, Lefter R, Jaber H, Balmus IM, Ciobica A, Iordache AC. The role of potential oxidative biomarkers in the pognosis of acute ischemic stroke and the exploration of antioxidants as possible preventive and treatment options. Int J Mol Sci 2023; 24(7):6389.
|
| [39] |
Xiong Y, Mahmood A, Chopp M. Neurorestorative treatments for traumatic brain injury. Discov Med 2010; 10:434-42.
|
| [40] |
Marcet P, Santos N, Borlongan CV. When friend turns foe: central and peripheral neuroinflammation in central nervous system injury. Neuroimmunol Neuroinflamm 2017; 4(5):82-92.
|
| [41] |
Das M, Mohapatra S, Mohapatra SS. New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflammation 2012; 9(1):236.
|
| [42] |
Ajmo CT Jr, Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA, et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol 2009; 218(1):47-55.
|
| [43] |
Ajmo CT Jr, Vernon DO, Collier L, Hall AA, Garbuzova-Davis S, Willing A, et al. The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res 2008; 86(10):2227-34.
|
| [44] |
Jin R, Zhu X, Liu L, Nanda A, Granger DN, Li G. Simvastatin attenuates strokeinduced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice. Stroke 2013; 44(4):1135-43.
|
| [45] |
Leiter O, Zhuo Z, Rust R, Wasielewska JM, Grönnert L, Kowal S, et al. Selenium mediates exercise-induced adult neurogenesis and reverses learning deficits induced by hippocampal injury and aging. Cell Metab 2022; 34(3):408-23.
|
| [46] |
De Miguel Z, Khoury N, Betley MJ, Lehallier B, Willoughby D, Olsson N, et al. Exercise plasma boosts memory and dampens brain inflammation via clusterin. Nature 2021; 600(7889):494-9.
|
| [47] |
Hudobenko J, Chauhan A, McCullough L; Jacob Hudobenko RVaLM. Abstract 128: amelioration of ischemic stroke damage through inhibition of interleukin-6 signaling with tocilizumab requires sex specific dosing. Stroke 2019; 50:Suppl_1.
|
| [48] |
Boczar KE, Shin S, Bezzina KA, Geejo A, Pearson AL, Shahab S, et al. Examining anti-inflammatory therapies in the prevention of cardiovascular events: protocol for a systematic review and network meta-analysis of randomised controlled trials. BMJ Open 2022; 12(6):e062702.
|
| [49] |
Khan R, Di Gesù CM, Lee J, McCullough LD. The contribution of age-related changes in the gut-brain axis to neurological disorders. Gut Microbes 2024; 16 (1):2302801.
|
| [50] |
Kingsbury C, Shear A, Heyck M, Sadanandan N, Zhang H, Gonzales-Portillo B, et al. Inflammation-relevant microbiome signature of the stroke brain, gut, spleen, and thymus and the impact of exercise. J Cereb Blood Flow Metab 2021; 41(12):3200-12.
|
| [51] |
Bonkhoff AK, Grefkes C. Precision medicine in stroke: towards personalized outcome predictions using artificial intelligence. Brain 2022; 145(2):457-75.
|
PDF(588 KB)
